Logo Image
News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable DiscussionsShortsShows & Podcasts
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesParkinsonism Practical GuideSponsoredThe G.L.O.B.Virtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
  • Movement Disorders
    • Parkinson Disease
    • Dyskinesia
    • Huntington Disease
  • Neuro-Oncology
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Excessive Daytime Sleepiness
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
Upcoming Live Events|
CMSC 2026|
ATMRD 2026|
Parkinsonism Practical Guide|
CIDP: Grip Strength
Advertisement

Sarah Zwerling

Advertisement

Articles by Sarah Zwerling

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

ByBecca Lassell, PhD, OTR,Katherine Wang, MD,Ada Metaxas, BS-C,Sarah Zwerling,Sara Hantgan, BSI-C,Prabhat Gottipati,Sunit P. Jariwala, MD, FAAAAI
April 30th 2024

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Advertisement

Latest Updated Articles

  • Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care
    Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

    April 30th 2024



Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

FDA Accepts sNDAs for Casimersen and Golodirsen, Chris Johnson Diagnosed with ALS, Phase 2 Trial of NEU-411 Expands

2

NeurologyLive® Brain Games: July 5, 2026

3

FDA Clears PoNS Device for Stroke Rehabilitation, Expanding Neurostimulation Beyond MS Indication

4

Where Tolebrutinib Fits: Weighing the EU Approval, FDA Divergence, and the Road Ahead in nrSPMS

5

PrimeC Achieves Primary Biomarker End Point in Phase 2b PARADIGM ALS Trial

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us